Senior insider sale
Chief Financial Officer at BICARA THERAPEUTICS INC. — senior position signals high conviction
$1.34M
49.70K shares
What this filing means
HYEP IVAN plans to sell 49.70K shares of BICARA THERAPEUTICS INC. valued at approximately $1.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001969223-26-000873
Officer· Chief Financial Officer
Since Mar 2026
49.70K
Shares to sell
$1.34M
Approx. market value
12.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
8/10/2026
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/10/2026 | Exercise of stock options Cash | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
28K
Market value
$807.7K
7/8/2026
—Completed
Units to sell
9.20K
Market value
$187.9K
5/21/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.50K
Market value
$347.9K
8/10/2026
Total
Units
49.70K
Value
$1.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2026 | 28K | $807.7K | — | Completed |
5/21/2026 | 9.20K | $187.9K | — | Completed |
| Planned — Approximate Date | ||||
8/10/2026 | 12.50K | $347.9K | NASDAQ | Planned |
| Total | 49.70K | $1.34M | ||